16.76

0.65% -0.11

After Hours: 16.78 0.02 +0.12%

Bausch Lomb Corp (BLCO)

Overview News Price History Option Chain Financials Discussions Forecast

Bausch Lomb Corp stock is traded at $16.76, with a volume of 387.57K. It is down -0.65% in the last 24 hours and up +3.27% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Previous Close:

$16.87

Open:

$16.63

24h Volume:

387.57K

Relative Volume:

0.89

Market Cap:

$5.99B

Revenue:

$5.21B

Net Income/Loss:

$-211.00M

P/E Ratio:

-27.12

EPS:

-0.6179

Net Cash Flow:

$861.30K

1W Performance:

+0.00%

1M Performance:

+3.27%

6M Performance:

+0.18%

1Y Performance:

+21.71%

1-Day Range:

$16.28

$16.89

1-Week Range:

$16.28

$17.05

52-Week Range:

$13.77

$18.91

Bausch Lomb Corp Stock (BLCO) Company Profile

Name

Bausch Lomb Corp

Sector

Healthcare (1075)

Industry

Medical Instruments & Supplies (57)

Phone

908-541-5456

Address

520 APPLEWOOD CRESCENT, VAUGHAN

Employee

13,000

Twitter

Next Earnings Date

2026-07-29

Latest SEC Filings

BLCO's Discussions on Twitter

Compare BLCO vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BLCO Bausch Lomb Corp	16.76	6.03B	5.21B	-211.00M	861.30K	-0.6179
ISRG Intuitive Surgical Inc	401.27	141.75B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.58	49.41B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	73.58	36.42B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	226.00	32.61B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.50	30.74B	29.14B	1.07B	1.05B	1.1956

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line
Dec-11-25	Upgrade	Citigroup	Neutral → Buy
Dec-02-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-01-25	Initiated	Goldman	Neutral
May-02-25	Reiterated	H.C. Wainwright	Buy
Mar-28-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-11-24	Downgrade	Citigroup	Buy → Neutral
Dec-02-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform
Jul-10-24	Initiated	Raymond James	Outperform
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-12-23	Initiated	Stifel	Hold
Oct-03-23	Resumed	Evercore ISI	Outperform
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight
Sep-12-22	Initiated	H.C. Wainwright	Buy
Jul-26-22	Initiated	RBC Capital Mkts	Outperform
Jun-24-22	Initiated	Evercore ISI	Outperform
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Deutsche Bank	Hold
May-31-22	Initiated	Goldman	Neutral
May-31-22	Initiated	Guggenheim	Buy
May-31-22	Initiated	JP Morgan	Neutral
May-31-22	Initiated	Jefferies	Buy
May-31-22	Initiated	Morgan Stanley	Equal-Weight
May-31-22	Initiated	Wells Fargo	Overweight
May-11-22	Initiated	Cowen	Outperform

View All

Bausch Lomb Corp Stock (BLCO) Latest News

Aug 12, 2026

Bausch + Lomb (NYSE:BLCO) CAO Sells 52,900 Shares - MarketBeat

Aug 12, 2026

Bausch & Lomb (BLCO) SVP Frederick Munsch sells 52,900 shares in August trade - Stock Titan

Aug 12, 2026

Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO? - simplywall.st

Aug 12, 2026

Form 8K Bausch & Lomb Corp For: 12 August By Investing.com - Investing.com South Africa

Aug 12, 2026

Form 8K Bausch & Lomb Corp For: 12 August - Investing.com India

Aug 12, 2026

Aug 11, 2026

BLCO (BLCO) shareholder plans NYSE sale of 52,900 restricted shares - Stock Titan

Aug 11, 2026

Aug 10, 2026

Bausch + Lomb (NYSE:BLCO) Director Eschenbach Andrew Von Sells 12,500 Shares - MarketBeat

Aug 10, 2026

Bausch & Lomb (NYSE: BLCO) director sells 18,559 shares after board exit - Stock Titan

Aug 10, 2026

Insider Selling: Bausch + Lomb (NYSE:BLCO) Director Sells $100,458.22 in Stock - MarketBeat

Aug 10, 2026

BLCO | Bausch + Lomb Corporation FinancialsIncome Statement - Quiver Quantitative

Aug 10, 2026

BLCO shareholder plans $887,885 stock sale (NYSE: BLCO) - Stock Titan

Aug 10, 2026

Bausch + Lomb Corporation (BLCO): Growth Potential and Analyst Ratings Point to an 11% Upside - DirectorsTalk Interviews

Aug 10, 2026

Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - visionmonday.com

Aug 10, 2026

Aug 09, 2026

Bausch + Lomb Corporation $BLCO Shares Bought by Sei Investments Co. - MarketBeat

Aug 09, 2026

Aug 08, 2026

BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure - Stocktwits

Aug 08, 2026

Aug 07, 2026

Bausch Lomb (BLCO) investor plans sale of 12,500 common shares - Stock Titan

Aug 07, 2026